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Background: To date no guidelines about implantation of Implantable Cardioverter Defibrillators (ICD) adults with Congenital Heart Disease (CHD) 
are present. Our aim was to investigate long term outcomes following ICD implantation and ICD related complications. 
Methods: Patients were identified from 2 centers in the Netherlands. Exclusion criteria were age <18 years and additional primary electrical 
disease or cardiomyopathy.
Results: Fourty-six patients underwent ICD implantation (mean age 44 years, range: 19-81, 65% male). Diagnosis included tetralogy of Fallot 
(39%), ventricular septal defect (16%), atrial septal defect (10%) and other (35%). ICDs were implanted for primary prevention in 27 patients 
(59%) and secondary prevention in 19 (41%). After a follow-up of 4,3 years (range 0-13) 17 patients (37%) received ≥1 appropriate and effective 
ICD shock. Appropriate shocks occurred in 14 (30%) and 22 (47%) of the primary and secondary prevention patients respectively. Thirty-eight 
inappropriate shocks occurred in 10 patients (22%), predominantly due to supraventricular tachycardias (table). No predictors for (in) appropriate 
shocks were identified. Additionally, 10 patients (22%) experienced complications of which 4 (9%) occurred peri-procedurally and 6 were (13%) late. 
Conclusions: ICD therapy appears to be safe and effective in adults with CHD, however the rate of inappropriate shocks needs further attention.
